The FDA approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients two years of age and older.
Click on this link to read the Official US Food & Drug Administration Press Release :
FDA approves first drug comprised of an active ingredient derived from marijuana to treat rare, severe forms of epilepsy
The video is courtesy of the All News YouTube channel
Click on this link to visit the New Scientist website to read their post titled: “First cannabis-based drug approved in the US to treat epilepsy”.
Click on this link to read about GW Pharmaceuticals plc Epidiolex development
Uniquely Toronto 